Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: A national study

Journal of Psychiatric Research

Volumn 50, Issue 1, 2014, Pages 26-35

  Wu, Li Tzy ^a   Brady, Kathleen T ^b   Mannelli, Paolo ^a   Killeen, Therese K ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Asian Americans; Cannabis use disorder; Mixed race; Native Americans; Pacific Islanders

Indexed keywords

ALCOHOL; CANNABIS; NICOTINE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CANNABIS ADDICTION; CAUCASIAN; CHILD; ETHNIC AND RACIAL GROUPS; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRIORITY JOURNAL; SCHOOL CHILD; SELF CONCEPT; SUBSTANCE USE; TOBACCO DEPENDENCE; YOUNG ADULT;

ASIAN AMERICANS; CANNABIS USE DISORDER; MIXED RACE; NATIVE AMERICANS; PACIFIC ISLANDERS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; ASIAN AMERICANS; CHILD; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; MALE; MARIJUANA ABUSE; MIDDLE AGED; PREVALENCE; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84892489884     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.11.010     Document Type: Article

References (57)

1. American Psychiatric Association Diagnostic and statistical Manual of mental disorders 2000, American Psychiatric Publishing, Washington, DC, [text revision]. 4th ed.
2. Bennett T., Holloway K., Farrington D. The statistical association between drug misuse and crime: a meta-analysis. Aggress Violent Behav 2008, 13:107-118.
3. Brook J.S., Richter L., Rubenstone E. Consequences of adolescent drug use on psychiatric disorders in early adulthood. Ann Med 2000, 32:401-407.
4. Cerdá M., Wall M., Keyes K.M., Galea S., Hasin D. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 2012, 120:22-27.
5. Duncan S.C., Duncan T.E., Strycker L.A. Amultilevel analysis of neighborhood context and youth alcohol and drug problems. Prev Sci 2002, 3:125-133.
6. DuRant R.H., Smith J.A., Kreiter S.R., Krowchuk D.P. The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents. Arch Pediat Adol Med 1999, 153:286-291.
7. Edwards C., Giroux D., Okamoto S.K. Areview of the literature on Native Hawaiian youth and drug use: implications for research and practice. J Ethn Subst Abuse 2010, 9:153-172.
8. Epstein J.F. Substance dependence, abuse, and treatment: findings from the 2000 national household survey on drug abuse 2002, [NHSDA series A-16, DHHS publication no. SMA 02-3642], Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
9. Friese B., Grube J.W. Legalization of medical marijuana and marijuana use among youths. Drugs (Abingdon Engl) 2013, 20:33-39.
10. Gfroerer J., Eyerman J., Chromy J. Redesigning an ongoing national household survey: methodological issues 2002, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD, [DHHS Publication No. SMA 03-3768].
11. Harrison L.D., Martin S.S., Enev T., Harrington D. Comparing drug testing and self-report of drug use among youths and young adults in the general population 2007, [DHHS publication no. SMA 07-4249, Methodology series M-7], Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
12. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127.
13. Hurd Y.L., Michaelides M., Miller M.L., Jutras-Aswad D. Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology 2014, 76:416-424.
14. Institute for Behavior and Health Marijuana use is a serious highway safety threat: 5 ng/ml marijuana impairment limits give drivers a free pass to drive stoned 2013 June 13, Available at. http://www.ibhinc.org/pdfs/IBHCommentaryMarijuanaandDruggedDriving61013.pdf.
15. Joffe A. American Academy of Pediatrics Committee on substance abuse; American Academy of Pediatrics Committee on adolescence. Legalization of marijuana: potential impact on youth. Pediatrics 2004, 113:1825-1826.
16. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the future national results on adolescent drug Use: Overview of key findings, 2011 2012, The University of Michigan, Institute for Social Research.
17. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602. [Erratum in Arch Gen Psychiatry 2005; 62:768. Merikangas, Kathleen R [added]].
18. Lev-Ran S., Imtiaz S., Taylor B.J., Shield K.D., Rehm J., Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2012, 123:190-200.
19. Levy S. Effects of marijuana policy on children and adolescents. JAMA Pediatr 2013 Jul 1, 167(7):600-602.
20. Lopez-Quintero C., Neumark Y. Effects of risk perception of marijuana use on marijuana use and intentions to use among adolescents in Bogotá, Colombia. Drug Alcohol Depend 2010, 109:65-72.
21. Lopez-Quintero C., Pérez de los Cobos J., Hasin D.S., Okuda M., Wang S., Grant B.F., et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011, 115(1-2):120-130.
22. Meier M.H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R.S., et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012, 109(40):E2657-E2664.
23. Najt P., Fusar-Poli P., Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res 2011, 186:159-164.
24. O'Callaghan F.V., Hannon T. Normalization of marijuana use: its effects on adolescents' intentions to use marijuana. Substance Use & Misuse 2003, 38:185-199.
25. O'Neil K.A., Conner B.T., Kendall P.C. Internalizing disorders and substance use disorders in youth: comorbidity, risk, temporal order, and implications for intervention. Clin Psychol Rev 2011, 31:104-112.
26. Office of National Drug Control Policy Arrestee Drug Abuse Monitoring (ADAM II) Program 2009 annual report: Arrestee drug abuse monitoring program II 2010, Executive Office of The President Washington, DC, [accessed 22.10.13]. http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/adam2009.pdf.
27. Plancherel B., Bolognini M., Stéphan P., Laget J., Chinet L., Bernard M., et al. Adolescents' beliefs about marijuana use: a comparison of regular users, past users and never/occasional users. JDrug Educ 2005, 35:131-146.
28. Realini N., Rubino T., Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharm Res 2009, 60:132-138.
29. RTI International SUDAAN User's Manual, Release 9.0 2006, RTI International, Research Triangle Park, NC.
30. Rubino T., Zamberletti E., Parolaro D. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. JPsychopharmacol 2012, 26:177-188.
31. Ruiz-Veguilla M., Barrigón M.L., Hernández L., Rubio J.L., Gurpegui M., Sarramea F., et al. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample. JPsychiatr Res 2013, 47:1036-1043.
32. Salomonsen-Sautel S., Sakai J.T., Thurstone C., Corley R., Hopfer C. Medical marijuana use among adolescents in substance abuse treatment. JAm Acad Child Adolesc Psychiatry 2012, 51:694-702.
33. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 2008, 13:253-263.
34. Schubart C.D., van Gastel W.A., Breetvelt E.J., Beetz S.L., Ophoff R.A., Sommer I.E., et al. Cannabis use at a young age is associated with psychotic experiences. Psychol Med 2011, 41:1301-1310.
35. Shiffman S., Waters A., Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004, 6:327-348.
36. Shih R.A., Miles J.N., Tucker J.S., Zhou A.J., D'Amico E.J. Racial/ethnic differences in adolescent substance use: mediation by individual, family, and school factors. J Stud Alcohol Drugs 2010 Sep, 71(5):640-651.
37. Stone J.M., Fisher H.L., Major B., Chisholm B., Woolley J., Lawrence J., et al. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med 2013, 1-8. [published online ahead of print May 24 2013].
38. Substance Abuse and Mental Health Services Administration Results from the 2005 national survey on drug use and health: national findings 2006, [Office of applied studies, NSDUH series H-30, DHHS publication no. SMA 06-4194. Rockville, MD].
39. Substance Abuse and Mental Health Services Administration Reliability of key measures in the national survey on drug use and health 2010, [Office of applied studies, Methodology series M-8, HHS publication no. SMA 09-4425. Rockville, MD].
40. Substance Abuse and Mental Health Services Administration Results from the 2011 national survey on drug use and health: Summary of national findings 2012, [NSDUH series H-44, HHS publication no. (SMA) 12-4713], Substance Abuse and Mental Health Services Administration, Rockville, MD.
41. Substance Abuse and Mental Health Services Administration Drug abuse warning network, 2010: national estimates of drug-related emergency department visits 2012, [HHS publication no. (SMA) 12-4733, DAWN series D-38], Substance Abuse and Mental Health Services Administration, Rockville, MD.
42. Substance Abuse and Mental Health Services Administration Center for behavioral health statistics and quality 2012, [Treatment Episode Data Set (TEDS): 2000-2010. National admissions to substance abuse treatment services. DASIS series S-61, HHS publication no. (SMA) 12-4701], Substance Abuse and Mental Health Services Administration, Rockville, MD.
43. Svrakic D.M., Lustman P.J., Mallya A., Lynn T.A., Finney R., Svrakic N.M. Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective. Missouri Med J 2012, 109:90-98.
44. Thurstone C., Lieberman S.A., Schmiege S.J. Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend 2011, 118:489-492.
45. Turner C.F., Ku L., Rogers S.M., Lindberg L.D., Pleck J.H., Sonenstein F.L. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science 1998, 280:867-873.
46. United Nations Office on Drugs and Crime (UNODC) United Nations publication World drug report, 2012 2012, [Sales No. E.12XI.1], UNODC, New York.
47. US Census Bureau Overview of race and Hispanic origin: 2010 2011, Economics and Statistics Administration, U.S. Department of Commerce, [accessed 05.11.12]. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf.
48. Werb D., Fischer B., Wood E. Cannabis policy: time to move beyond the psychosis debate. Int J Drug Policy 2010, 21:261-264.
49. Wilson J.M., Donnermeyer J.F. Urbanity, rurality, and adolescent substance use. Crim Just Rev 2006, 31:337-356.
50. Winters K.C., Martin C.S., Chung T. Substance use disorders in DSM-V when applied to adolescents. Addict 2011 May, 106(5):882-884.
51. Wu L.T., Pilowsky D.J., Patkar A.A. Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend 2008, 94:1-11.
52. Wu L.T., Gersing K., Burchett B., Woody G.E., Blazer D.G. Substance use disorders and comorbid axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. JPsychiatr Res 2011, 45:1453-1462.
53. Wu L.T., Woody G.E., Yang C., Pan J.J., Blazer D.G. Racial/ethnic variations in substance-related disorders among adolescents in the United States. Arch Gen Psychiat 2011, 68:1176-1185.
54. Wu L.T., Woody G.E., Yang C., Pan J.J., Reeve B.B., Blazer D.G. Adimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults. Int J Methods Psychiatr Res 2012, 21(2):117-133.
55. Wu L.T., Gersing K.R., Swartz M.S., Burchett B., Li T.K., Blazer D.G. Using electronic healthrecords data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. JPsychiatr Res 2013, 47:555-563.
56. Wu L.T., Swartz M.S., Burchett B., Workgroup N.A., Blazer D.G. Tobacco use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals: 2002-2010. Drug Alcohol Depend 2013, 132:87-94.
57. Wu L.T., Blazer D.G., Gersing K., Burchett B., Swartz M.S., Mannelli P. NIDA AAPI Workgroup. Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. JPsychiatr Res 2013 Dec, 47(12):1940-1948. http://dx.doi.org/10.1016/j.jpsychires.2013.08.022.